{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:58:29Z","timestamp":1766757509723,"version":"3.48.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.steroids.2025.109703","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:10:06Z","timestamp":1760998206000},"page":"109703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Soy isoflavone Daidzein resembling the vertebrate steroid structure exhibits neuroprotection via mitochondrial biogenesis in rotenone induced Parkinson\u2019s disease in preclinical model"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-0483","authenticated-orcid":false,"given":"Vaibhavi","family":"Peshattiwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Muke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakruti","family":"Kaikini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Bagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-0994","authenticated-orcid":false,"given":"Sadhana","family":"Sathaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.steroids.2025.109703_b0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.steroids.2025.109703_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"\u201cParkinson's disease: mechanisms and models,\u201d (in eng)","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/187152712800792893","article-title":"Motor and Non-Motor Features of Parkinson\u2019s Disease \u2013 a Review of Clinical and Experimental Studies","volume":"11","author":"Marcelo","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"7","key":"10.1016\/j.steroids.2025.109703_b0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1750-3639.2002.tb00468.x","article-title":"Mechanistic Approaches to Parkinson's Disease Pathogenesis","volume":"12","author":"Betarbet","year":"2002","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"\u201cUnderstanding Dopaminergic Cell Death Pathways in Parkinson Disease,\u201d (in eng)","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.steroids.2025.109703_b0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"\u201cChronic systemic pesticide exposure reproduces features of Parkinson's disease,\u201d (in eng)","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.steroids.2025.109703_b0050","doi-asserted-by":"crossref","unstructured":"M. M. Braun and L. Puglielli, \u201cDefective PTEN-induced kinase 1\/Parkin mediated mitophagy and neurodegenerative diseases,\u201d (in English), Frontiers in Cellular Neuroscience, Review vol. Volume 16 - 2022, 2022-October-20 2022, doi: 10.3389\/fncel.2022.1031153.","DOI":"10.3389\/fncel.2022.1031153"},{"issue":"35","key":"10.1016\/j.steroids.2025.109703_b0055","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.2174\/1381612820666140305224906","article-title":"\u201cMitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases,\u201d (in eng)","volume":"20","author":"Uittenbogaard","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.steroids.2025.109703_b0060","doi-asserted-by":"crossref","unstructured":"M. Morissette, N. Litim, and T. Di Paolo, \u201cChapter 2 - Natural Phytoestrogens: A Class of Promising Neuroprotective Agents for Parkinson Disease,\u201d in Discovery and Development of Neuroprotective Agents from Natural Products, G. Brahmachari Ed.: Elsevier, 2018, pp. 9-61.","DOI":"10.1016\/B978-0-12-809593-5.00002-1"},{"key":"10.1016\/j.steroids.2025.109703_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6331630","article-title":"\u201cTherapeutic potential of Isoflavones with an Emphasis on Daidzein,\u201d (in eng)","volume":"2021","author":"Alshehri","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.steroids.2025.109703_b0070","unstructured":"K. D. Setchell, \u201cPhytoestrogens: the biochemistry, physioligy, and implications for human health of soy isoflavounes,\u201d Am J Clin Nutr, vol. 68, pp. l333s-l346s, 1998 1998. [Online]. Available: https:\/\/cir.nii.ac.jp\/crid\/1574231874282617088."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1248\/cpb.c20-00706","article-title":"Structure\u2013Activity Relationship of Phytoestrogen Analogs as ER\u03b1\/\u03b2 Agonists with Neuroprotective Activities","volume":"69","author":"Cho","year":"2021","journal-title":"Chem. Pharm. Bull."},{"issue":"16","key":"10.1016\/j.steroids.2025.109703_b0080","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1021\/jm100610w","article-title":"\u201cEffects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells,\u201d (in eng)","volume":"53","author":"Jiang","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.steroids.2025.109703_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/efd2.70008","article-title":"A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status","volume":"5","author":"Ahmad","year":"2024","journal-title":"eFood"},{"key":"10.1016\/j.steroids.2025.109703_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118157","article-title":"Daidzein effectively mitigates amyloid-\u03b2-induced damage in SH-SY5Y neuroblastoma cells and C6 glioma cells","volume":"187","author":"\u00d6zdemir","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.steroids.2025.109703_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22319","article-title":"\u201cProtective effect of daidzein against streptozotocin-induced Alzheimer's disease via improving cognitive dysfunction and oxidative stress in rat model,\u201d (in eng)","volume":"33","author":"Wei","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0100","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1111\/j.1365-2621.2005.tb07122.x","article-title":"Protective Effects of Daidzein on Oxidative Stress-Induced Neurotoxicity and Scopolamine-Mediated Cognitive defect","volume":"70","author":"Jin","year":"2005","journal-title":"J. Food Sci."},{"issue":"10","key":"10.1016\/j.steroids.2025.109703_b0105","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s12272-010-1019-2","article-title":"\u201cThe effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice,\u201d (in eng)","volume":"33","author":"Kim","year":"2010","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.steroids.2025.109703_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037540","article-title":"\u201cSoy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure,\u201d (in eng)","volume":"7","author":"Adams","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12640-012-9328-5","article-title":"\u201cAnti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: implications for Parkinson's disease,\u201d (in eng)","volume":"23","author":"Chinta","year":"2013","journal-title":"Neurotox. Res."},{"issue":"17","key":"10.1016\/j.steroids.2025.109703_b0120","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.phytochem.2010.08.015","article-title":"Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells","volume":"71","author":"Lin","year":"2010","journal-title":"Phytochemistry"},{"issue":"11","key":"10.1016\/j.steroids.2025.109703_b0125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jnutbio.2015.05.010","article-title":"Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells","volume":"26","author":"Yoshino","year":"2015","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0130","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1038\/s41598-022-20215-6","article-title":"PGC-1\u03b2 maintains mitochondrial metabolism and restrains inflammatory gene expression","volume":"12","author":"Guak","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.steroids.2025.109703_b0135","first-page":"51","article-title":"\u201cGenistein, daidzein, and resveratrols stimulate PGC-1\u03b2-mediated gene expression,\u201d (in eng)","volume":"17","author":"Uchitomi","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"year":"2005","series-title":"The Rat Brain in Stereotaxic Coordinates - the New Coronal Set","author":"Paxinos","key":"10.1016\/j.steroids.2025.109703_b0140"},{"issue":"7","key":"10.1016\/j.steroids.2025.109703_b0145","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3390\/12071455","article-title":"\u201cThe anti-apoptosis effects of daidzein in the brain of D-galactose treated mice,\u201d (in eng)","volume":"12","author":"Mao","year":"2007","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.steroids.2025.109703_b0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s002040000149","article-title":"Toxicokinetics of the phytoestrogen daidzein in female DA\/Han rats","volume":"74","author":"Janning","year":"2000","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.steroids.2025.109703_b0155","doi-asserted-by":"crossref","unstructured":"R. J. Carter, J. Morton, and S. B. Dunnett, \u201cMotor coordination and balance in rodents,\u201d (in eng), Curr Protoc Neurosci, vol. Chapter 8, p. Unit 8.12, Aug 2001, doi: 10.1002\/0471142301.ns0812s15.","DOI":"10.1002\/0471142301.ns0812s15"},{"key":"10.1016\/j.steroids.2025.109703_b0160","series-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests","first-page":"1","article-title":"The Open Field Test","author":"Gould","year":"2009"},{"issue":"15","key":"10.1016\/j.steroids.2025.109703_b0165","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"\u201cA transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss,\u201d (in eng)","volume":"33","author":"Cohen","year":"2013","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.steroids.2025.109703_b0170","article-title":"\u201cCognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease,\u201d (in eng)","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.steroids.2025.109703_b0175","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1021\/jf204970r","article-title":"Improved Pyrogallol Autoxidation Method: a Reliable and cheap Superoxide-Scavenging Assay Suitable for all Antioxidants","volume":"60","author":"Li","year":"2012","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.steroids.2025.109703_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02712155","article-title":"Assay of superoxide dismutase activity in animal tissues","volume":"13","author":"Nandi","year":"1988","journal-title":"J. Biosci."},{"key":"10.1016\/j.steroids.2025.109703_b0185","series-title":"\u201ccatalase,\u201d in Methods of Enzymatic Analysis (second Edition)","first-page":"673","author":"Aebi","year":"1974"},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-2697(72)90132-7","article-title":"Colorimetric assay of catalase","volume":"47","author":"Sinha","year":"1972","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.steroids.2025.109703_b0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0200","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0003-2697(88)90564-7","article-title":"Assay of glutathione reductase in crude tissue homogenates using 5,5\u2032-dithiobis(2-nitrobenzoic acid)","volume":"175","author":"Smith","year":"1988","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0210","doi-asserted-by":"crossref","first-page":"2.4.1","DOI":"10.1002\/0471140856.tx0204s00","article-title":"Measurement of Lipid Peroxidation","volume":"00","author":"Reilly","year":"1999","journal-title":"Curr. Protoc. Toxicol."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1440-1789.1999.00196.x","article-title":"\u201cTyrosine hydroxylase-immunoreactive neurons are decreased in number in the cerebral cortex of Parkinson's disease,\u201d (in eng)","volume":"19","author":"Fukuda","year":"1999","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.steroids.2025.109703_b0220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00702-007-0860-z","article-title":"\u201cTime dependent changes of striatal interneurons after focal cerebral ischemia in rats,\u201d (in eng)","volume":"115","author":"Sakuma","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"6","key":"10.1016\/j.steroids.2025.109703_b0225","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nprot.2012.058","article-title":"Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells","volume":"7","author":"Spinazzi","year":"2012","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"\u201cThe MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments,\u201d (in eng)","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"\u201cAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method,\u201d (in eng)","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"11","key":"10.1016\/j.steroids.2025.109703_b0240","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd.2018.136","article-title":"\u201cTherapeutic strategies for Parkinson disease: beyond dopaminergic drugs,\u201d (in eng)","volume":"17","author":"Charvin","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.steroids.2025.109703_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100274","article-title":"Current therapeutic strategies in Parkinson\u2019s disease: Future perspectives","volume":"48","author":"Kim","year":"2025","journal-title":"Mol. Cells"},{"key":"10.1016\/j.steroids.2025.109703_b0250","doi-asserted-by":"crossref","unstructured":"W. H. Oertel, \u201cRecent advances in treating Parkinson's disease,\u201d (in eng), F1000Res, vol. 6, p. 260, 2017, doi: 10.12688\/f1000research.10100.1.","DOI":"10.12688\/f1000research.10100.1"},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0255","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"\u201cAcute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease,\u201d (in eng)","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.steroids.2025.109703_b0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2010.03.019","article-title":"\u201cA study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats,\u201d (in eng)","volume":"272","author":"Swarnkar","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.steroids.2025.109703_b0265","doi-asserted-by":"crossref","unstructured":"N. Xiong et al., \u201cStereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease,\u201d (in eng), PLoS One, vol. 4, no. 11, p. e7878, Nov 18 2009, doi: 10.1371\/journal.pone.0007878.","DOI":"10.1371\/journal.pone.0007878"},{"issue":"3","key":"10.1016\/j.steroids.2025.109703_b0270","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-011-9278-3","article-title":"\u201cBehavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin,\u201d (in eng)","volume":"21","author":"Moreira","year":"2012","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.steroids.2025.109703_b0275","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.steroids.2025.109703_b0280","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"\u201cInflammation as a causative factor in the aetiology of Parkinson's disease,\u201d (in eng)","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"\u201cSelective microglial activation in the rat rotenone model of Parkinson's disease,\u201d (in eng)","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.steroids.2025.109703_b0290","doi-asserted-by":"crossref","unstructured":"P. Troncoso-Escudero, A. Parra, M. Nassif, and R. L. Vidal, \u201cOutside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease,\u201d (in eng), Front Neurol, vol. 9, p. 860, 2018, doi: 10.3389\/fneur.2018.00860.","DOI":"10.3389\/fneur.2018.00860"},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"\u201cNeuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease,\u201d (in eng)","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.steroids.2025.109703_b0300","series-title":"Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease","first-page":"385","article-title":"Chapter 39 - Neuroprotection by Dietary Isoflavones and their Role in Cerebral Ischemia","author":"Schreihofer","year":"2015"},{"key":"10.1016\/j.steroids.2025.109703_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.105060","article-title":"Daidzein alleviates neuronal damage and oxidative stress via GSK3\u03b2\/Nrf2 pathway in mice","volume":"92","author":"Wang","year":"2022","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.steroids.2025.109703_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149840","article-title":"Daidzein targets PI3K-akt signaling and oxidative stress in glioblastoma: an Integrated pharmacological and in vitro study","volume":"1863","author":"Praisthy","year":"2025","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0315","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22949","article-title":"\u201cDaidzein exerts neuroprotective activity against MPTP-induced Parkinson's disease in experimental mice and lipopolysaccharide-induced BV2 microglial cells,\u201d (in eng)","volume":"36","author":"Wu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/09731296221137378","article-title":"Daidzein Ameliorates Cerebral Ischemic-reperfusion Induced Neuroinflammation in Wistar Rats via Inhibiting NF-\u03baB Signaling Pathway","volume":"19","author":"Zhang","year":"2023","journal-title":"Pharmacogn. Mag."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ars.2009.2668","article-title":"\u201cLipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities,\u201d (in eng)","volume":"12","author":"Adibhatla","year":"2010","journal-title":"Antioxid. Redox Signal."},{"issue":"7097","key":"10.1016\/j.steroids.2025.109703_b0330","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2025.109703_b0335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"\u201cCurrent understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments,\u201d (in eng)","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.steroids.2025.109703_b0340","doi-asserted-by":"crossref","unstructured":"J. S. Park, R. L. Davis, and C. M. Sue, \u201cMitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives,\u201d (in eng), Curr Neurol Neurosci Rep, vol. 18, no. 5, p. 21, Apr 3 2018, doi: 10.1007\/s11910-018-0829-3.","DOI":"10.1007\/s11910-018-0829-3"},{"key":"10.1016\/j.steroids.2025.109703_b0345","article-title":"\u201cMitochondrial contribution to Parkinson's disease pathogenesis,\u201d (in eng)","volume":"2011","author":"Schapira","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.steroids.2025.109703_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108315","article-title":"\u201cDaidzein promotes the expression of oxidative phosphorylation- and fatty acid oxidation-related genes via an estrogen-related receptor \u03b1 pathway to decrease lipid accumulation in muscle cells,\u201d (in eng)","volume":"77","author":"Kitamura","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.steroids.2025.109703_b0355","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/jcb.21936","article-title":"\u201cEstrogenic control of mitochondrial function and biogenesis,\u201d (in eng)","volume":"105","author":"Klinge","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0360","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/jpet.107.134882","article-title":"\u201cIsoflavones promote mitochondrial biogenesis,\u201d (in eng)","volume":"325","author":"Rasbach","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.steroids.2025.109703_b0365","doi-asserted-by":"crossref","unstructured":"Y. C. Chuang, S. D. Chen, C. Y. Hsu, S. F. Chen, N. C. Chen, and S. B. Jou, \u201cResveratrol Promotes Mitochondrial Biogenesis and Protects against Seizure-Induced Neuronal Cell Damage in the Hippocampus Following Status Epilepticus by Activation of the PGC-1\u03b1 Signaling Pathway,\u201d (in eng), Int J Mol Sci, vol. 20, no. 4, Feb 25 2019, doi: 10.3390\/ijms20040998.","DOI":"10.3390\/ijms20040998"},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0370","first-page":"23","article-title":"\u201cComparison of mitochondrial-related transcriptional levels of TFAM, NRF1 and MT-CO1 genes in single human oocytes at various stages of the oocyte maturation,\u201d (in eng)","volume":"19","author":"Ghaffari Novin","year":"2015","journal-title":"Iran. Biomed. J."},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0375","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/jc.2006-2210","article-title":"\u201cMarkers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects,\u201d (in eng)","volume":"92","author":"Heilbronn","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.steroids.2025.109703_b0380","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"\u201cInteraction of estrogenic chemicals and phytoestrogens with estrogen receptor beta,\u201d (in eng)","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.steroids.2025.109703_b0385","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/en.2008-0715","article-title":"A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor \u03b2-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo","volume":"150","author":"Zhao","year":"2009","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.steroids.2025.109703_b0390","first-page":"888","article-title":"\u201cDaidzein improves neuronal health and alleviates inflammation and apoptosis through BDNF and estrogen receptors in the hippocampus of ovariectomized rats,\u201d (in eng)","volume":"28","author":"Neisy","year":"2025","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.steroids.2025.109703_b0395","article-title":"\u201cNeuroprotective effect of Daidzein Extracted from Pueraria lobate Radix in a Stroke Model Via the Akt\/mTOR\/BDNF Channel,\u201d (in eng)","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.steroids.2025.109703_b0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/biof.1701","article-title":"\u201cAnti-neuroinflammatory effect of daidzein in human hypothalamic GnRH neurons in an in vitro membrane-based model,\u201d (in eng)","volume":"47","author":"Morelli","year":"2021","journal-title":"Biofactors"},{"issue":"11","key":"10.1016\/j.steroids.2025.109703_b0405","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.25122\/jml-2023-0082","article-title":"\u201cNeuroprotective effects of daidzein against ifosfamide-induced neurotoxicity in male rats: role of selected inflammatory and apoptotic markers,\u201d (in eng)","volume":"16","author":"Hammoodi","year":"2023","journal-title":"J. Med. Life"},{"issue":"4","key":"10.1016\/j.steroids.2025.109703_b0410","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1007\/s12035-024-04567-w","article-title":"\u201cNeuroprotective Roles of Daidzein through Extracellular Signal-Regulated Kinases Dependent Pathway In Chronic Unpredictable Mild stress Mouse Model,\u201d (in eng)","volume":"62","author":"Nisha","year":"2025","journal-title":"Mol. Neurobiol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X25001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X25001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:54:35Z","timestamp":1766757275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X25001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":82,"alternative-id":["S0039128X25001448"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109703","relation":{},"ISSN":["0039-128X"],"issn-type":[{"type":"print","value":"0039-128X"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soy isoflavone Daidzein resembling the vertebrate steroid structure exhibits neuroprotection via mitochondrial biogenesis in rotenone induced Parkinson\u2019s disease in preclinical model","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109703"}}